Which of the following anticancer drugs are competitive inhibitors of tyrosine kinase ?
Correct Answer: Imatinib and suntinib
Description: Ans. is 'a' i.e., Imatinib and suntinib Molecular targeted agents Tyrosine kinase inhibitors Competitive inhibitors - Imatinib, Nilotinib, Sunitinib, Dasatinib, Erlotinib, Gefitinib, Lapitinib, Sorafinib (Remember all ends with ' nib'). Monoclonal antibodies - Cetuximab, panitumomab. HER2/neu (ERB B2) inhibitors Monoclonal antibody - Transtuzumab. Targeted antibody - Gemtuzomab (anti CD-33), Rituximab (anti - CD20), Alemtuzumab (anti CD-52). Vascular endothelial growth factor (VEGF) inhibitor - Monoclonal antibody - Bevacizumab. Proteosome inhibitors - Boezomib. Histone deacylase inhibitor - Vorinostat DNA - methyl transferase inhibitor - 5-azacytidine, 2-deoxy-5 azacytidine. All - trans - retinoic acid. Biological response modifier - Recombinant IL-2 (aldesleukin, denileukin).
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now